chapter  1
Combined Contrast and Therapeutic Nanocarriers for Oncologic MRI
Pages 18

Table 1.1 Preferable release pattern of various nanocarriers Nanocarriers Preferable release patternPassively targeted drug nanocarriers Drugs should be released in the tumor and not in the systemic circulation.Actively targeted drug nanocarriers Drugs should be released only after the nanocarriers reach their intended target cells/receptors.Nanocarrier-based imaging agents Imaging agents should not be released and remain stably conjugated to track the distribution of nanocarriers.